ADMA vs DASH · P/E 22, rev $426.5M vs P/E 76, rev $13.72B
ADMA Biologics Inc (ADMA) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the ADMA and DASH stock pages for the full models.
Not investment advice.